Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
about
Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationMolecular imaging and therapy targeting copper metabolism in hepatocellular carcinomaNew approaches for precise response evaluation in hepatocellular carcinomaJoint analysis of multiple high-dimensional data types using sparse matrix approximations of rank-1 with applications to ovarian and liver cancerNuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantationCholine kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Hepatobiliary quiz-12 (2014).APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.The next generation of positron emission tomography radiopharmaceuticals in oncology.Imaging for assessment of treatment response in hepatocellular carcinoma: Current update.Transbilayer phospholipids molecular imaging.Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT.A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: InflueMetabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis.Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetate[(11)C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in MiceFDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis.Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.Non-FDG PET in oncology.Functional imaging techniques in hepatocellular carcinoma.The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review.Current molecular imaging positron emitting radiotracers in oncology.Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis.The role of imaging in the surveillance and diagnosis of hepatocellular cancer.Clinical applications of positron emission tomography in hepatic tumors.Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.Imaging Hepatocellular Carcinoma With 68Ga-Citrate PET: First Clinical Experience.Metabolic positron emission tomography imaging of cancer: Pairing lipid metabolism with glycolysisFeasibility of sequential PET/MRI using a state-of-the-art small animal PET and a 1 T benchtop MRI.[18F]Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling.Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers.PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.Diagnostic accuracy of ¹¹C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma.PET imaging of hepatocellular carcinoma with 18F-fluoroethylcholine and 11C-choline.18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.[Modern CT and PET/CT imaging of the liver].
P2860
Q26772329-C30A012E-7CE3-49E2-ADDE-F158731FA46DQ26772332-815A3CFA-40CE-4E9B-97BA-0F15486E4A47Q26866367-A94A8200-99CC-4FDB-9A84-A53E8995E964Q28595658-5096C98F-A18B-458F-AF20-F102F2729B2CQ33594891-7094F86F-7AED-4B41-B723-58756FC163A1Q34447257-E9DE8B63-C64A-4E47-998A-C3DCB7B4EA0CQ34826535-B06F39FA-AB24-4B4D-9DC5-D7DDD4395B46Q34983479-137BEE2A-4304-4CB9-835F-7F3EC017C066Q35207736-8240A58B-F779-45AE-8007-06115A0A7540Q35525690-7523A96C-B1C7-4322-B4D7-C33B82AADC32Q35568722-887FEAA4-5E9C-4D0D-854F-DAC4891BABBCQ35650805-85808D61-DD2E-4700-AAFE-18C06836D0C3Q35747156-F4759C82-2D6B-4235-B0C9-CAB4ED145F9BQ36195528-2BC98805-E59B-4AB5-84F8-C9D7A1242EADQ36568339-298DC352-807F-4622-AE8A-CFE6B27FAB4AQ36687495-1115F098-A0F7-4346-8392-25123BF5AEFCQ36900941-5489B404-9B1A-4223-AC96-1B2E5DAE88D7Q37077295-06009763-8BFA-45E9-A0DF-1636006BCA7EQ37077299-B9B9DE76-4B06-4DF8-9311-848E01144DCFQ37644820-C19ADC8B-AD2A-460C-89DC-25E505D26434Q37956045-0D109229-096C-4F51-98F5-BB4EF58C28E4Q37995486-B5393035-7A11-4F68-9655-DAEF7F2D4094Q38008241-425F7EE4-1FBC-433E-A451-B4DC24DFBFD3Q38217835-62D97BB2-F569-49FD-BD95-1EEAFD54F863Q38552509-24516469-EAEE-4F97-B258-62D4079BF9CFQ39040960-D44F7F99-474A-40BA-A596-B9B83966404DQ39734745-836B2D52-EAF7-4E76-B978-C62AC9388E7EQ40128040-FA35F83E-AB46-4806-B022-61D938147170Q41078929-DB99532B-2DB5-4505-981F-03C7F4160D3CQ42364439-A14C48BA-426A-4D31-B16F-C0C7848A2CBEQ45719364-0483F957-D672-4577-B193-16A502BA57E3Q46469807-D280C24F-607E-4410-931D-F72AF32E5DD1Q46506999-451175FD-065B-4F9A-B312-00B038B9384DQ48284532-26791F32-7805-40FF-8A12-DDAF2A5C1D16Q50099352-E0F6A39D-F6B7-4458-80B5-7BDAF16DD6A4Q50978599-496A1197-FEF1-4837-9BBD-BE6CC5230C9CQ51378631-D1F65D06-BF86-4563-A919-2113A14DA5EDQ52983338-35D810FA-E089-4A7B-A9E1-F8366739A2B1Q52988390-C50393F9-AE66-4D36-A5D2-9DF48C696809Q53212857-272EB5FE-F206-4786-9EC1-1B25C4C8A3CF
P2860
Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Detection of hepatocellular ca ...... osis or chronic liver disease.
@ast
Detection of hepatocellular ca ...... osis or chronic liver disease.
@en
Detection of hepatocellular ca ...... osis or chronic liver disease.
@nl
type
label
Detection of hepatocellular ca ...... osis or chronic liver disease.
@ast
Detection of hepatocellular ca ...... osis or chronic liver disease.
@en
Detection of hepatocellular ca ...... osis or chronic liver disease.
@nl
prefLabel
Detection of hepatocellular ca ...... osis or chronic liver disease.
@ast
Detection of hepatocellular ca ...... osis or chronic liver disease.
@en
Detection of hepatocellular ca ...... osis or chronic liver disease.
@nl
P2093
P1476
Detection of hepatocellular ca ...... osis or chronic liver disease.
@en
P2093
David Ancel
Fabrice Gutman
Jean-Didier Grange
Jean-Noël Talbot
Khaldoun Kerrou
Laetitia Fartoux
Olivier Rosmorduc
Sona Balogova
Valérie Nataf
Virginie Huchet
P304
P356
10.2967/JNUMED.110.075507
P407
P577
2010-10-18T00:00:00Z